{"id":17524,"date":"2025-12-05T10:12:39","date_gmt":"2025-12-05T09:12:39","guid":{"rendered":"https:\/\/www.gutblick.ch\/de\/?post_type=service&p=17524"},"modified":"2025-12-08T17:00:31","modified_gmt":"2025-12-08T16:00:31","slug":"current-research-projects-information-for-patients","status":"publish","type":"service","link":"https:\/\/www.gutblick.ch\/de\/leistungen\/currentresearchprojects-patienten\/","title":{"rendered":"Current research projects \u2013 Information for patients"},"content":{"rendered":"

Current <\/span>
research projects<\/h1 >
<\/p > <\/div >
$\"\"$ <\/div > <\/div > <\/div > <\/div > <\/div > \n\n
Research is important so that we can better understand eye diseases and develop new treatments. At Gutblick’s ophthalmology practices, we regularly conduct research projects\u2014for example, on retinal diseases, eye infections, or new medications. All research projects are conducted under medical supervision and in accordance with legal requirements.<\/p>\n<\/div><\/div><\/div><\/div>\n\n
Current research projects<\/h2>\n<\/div>
\n
$\"\"$ <\/p>\n
Research areas: <\/strong> Our research focuses on the macula, uveitis, retina, and state-of-the-art imaging diagnostics. Below you will find our current studies:<\/div>\n<\/div>\n<\/div><\/div><\/div><\/div>\n\n
Macular and retinal diseases<\/li>
Systemic diseases and ocular effects<\/li><\/ul><\/div>
Spectrum<\/h4>
\r\n
\r\n Description <\/strong>
\r\nAn observational study program to evaluate the effectiveness of the drug aflibercept 8 mg in the treatment of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) under real-world conditions.\r\n

\r\nGoal of the study<\/strong>
\r\nThis observational study aims to learn more about changes in visual acuity in patients with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) after starting treatment with the active ingredient aflibercept 8 mg.\r\n

\r\nWho can participate?<\/strong>
\r\nRecruitment completed\r\n

\r\n Locations <\/strong>
\r\nBern, Wallisellen, Aarau, Wetzikon
\r\n<\/p><\/body>\r\n<\/html><\/p><\/div>
CAMBRIA-2<\/h4>
\r\n
\r\n Description <\/strong>
\r\nThe international Phase III CAMBRIA-2 study is investigating the efficacy and safety of the new breast cancer drug camizestrant. For us, it is particularly relevant whether the drug causes any side effects in the eye.\r\n

\r\nGoal of the study<\/strong>
\r\nThe aim of the CAMBRIA-2 study is to investigate whether camizestrant can reduce the relapse rate in patients with early ER+\/HER2- breast cancer compared to the standard therapies currently available.\r\n

\r\nWho can participate?<\/strong>
\r\nPatients are recruited exclusively by the Tumor- und BrustZentrum Ostschweiz. We do not directly admit patients, but rather perform ophthalmological examinations as part of the study.\r\n

\r\n Locations <\/strong>
\r\nSt. Gallen \u2013 in collaboration with the Tumor- und BrustZentrum Ostschweiz
\r\n
\r\n Procedure <\/strong>
\r\nPatients are referred to us by the Tumor- und BrustZentrum Ostschweiz. The ophthalmological examinations take place in St. Gallen. We work closely with patients over several years and systematically record any possible side effects of the new medication on the eye.
\r\n<\/p><\/body>\r\n<\/html><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n\n
Frequently asked questions<\/h2>\n<\/div>
Many patients have questions about research in ophthalmology, such as what studies actually are or what consent means. We are happy to answer the most frequently asked general questions below.<\/p>\n<\/div><\/div><\/div><\/div>\n\n
<\/h3>
Research is about gaining new insights in order to improve medicine. In ophthalmology, research is conducted to develop better diagnostic methods, more effective treatments, and new technologies. Research helps to provide patients with optimal care.<\/p><\/div><\/div>
Better treatment options: <\/strong> <\/br>\r\nOne goal is to develop effective therapies for eye diseases. <\/br> <\/br>\r\nEarly detection: <\/strong> <\/br>\r\nAnother goal is to detect diseases at an early stage in order to prevent damage. <\/br> <\/br>\r\nNew technologies:<\/strong><\/br>\r\nA further goal is to improve diagnoses and treatments. <\/br><\/p><\/div><\/div>
Academic research<\/strong> <\/br>\r\nAcademic research uses existing knowledge and data to develop practical solutions, such as new drugs or devices.<\/br> <\/br>\r\n\r\nClinical research<\/strong> <\/br>\r\nClinical research tests drugs or therapies directly on patients. The aim is to verify their efficacy and safety.<\/br> <\/p><\/div><\/div>
In research, studies are used to test new treatment options. There are two types of studies:<\/br> <\/br> \r\n1) Clinical studies (with patients)<\/strong> <\/br> \r\nClinical studies apply drugs or therapies directly to humans.\r\nThe aim is to test the effectiveness of the therapy or to determine the dosage and safety of the drug.<\/br> <\/br>\r\n\r\n2) Non-clinical studies (in the laboratory)<\/strong> <\/br> \r\nNon-clinical studies test new active substances or devices on cells or animals. This is done to check safety before the active substances or devices are tested on humans.<\/br> \r\nNon-clinical studies are not offered at Gutblick. <\/p><\/div><\/div>
Patients must give their consent before participating in studies. There are two types of consent. Both ensure that patients participate in studies in an informed and voluntary manner: <\/br> <\/br> \r\n\r\nGeneral declaration of consent (general consent)<\/strong><\/br> \r\nA general declaration of consent allows patient data to be used for studies. The data is anonymized or encrypted for further use. Example: A patient agrees that their data (e.g., measurements) may be used for research.<\/br> <\/br> \r\n\r\nDeclaration of consent (for a specific study)<\/strong><\/br> \r\nA declaration of consent refers to a specific study. Patients receive all information about the procedure, objectives, and possible risks during the consultation. This information is always provided to the patient by a study physician, who also answers any questions.<\/p><\/div><\/div>
Fill out our contact form. We will then get back to you. <\/br><\/p><\/div><\/div><\/div><\/div><\/div><\/div>\n\n
Contact<\/h2>\n<\/div><\/div><\/div><\/div>\n\n